PLEASANTON, Calif., July 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 countries with Veeva OpenData and Veeva Network. Accurate and comprehensive customer reference data from OpenData will equip Boehringer Ingelheim's teams with the insights needed to engage healthcare professionals (HCPs) with relevant information, while laying the data foundation to scale AI."Extending our trusted p ...

Core Insights - Veeva Systems has launched the Veeva China Campaign Manager, a solution aimed at enhancing omnichannel engagement for pharmaceutical companies in China, focusing on compliance and customer experience [1][4][6] - This launch reflects Veeva's strategy to localize and innovate its offerings in high-growth international markets, particularly as digital engagement becomes essential in life sciences [2][4] - The Veeva China Campaign Manager is designed to meet the unique regulatory and commercial needs of the Chinese market, providing tools for effective and personalized campaigns [4][7] Company Performance - Following the announcement of the new campaign manager, Veeva's shares closed flat at $284.58, but have seen a year-to-date increase of 34.4%, outperforming the industry growth of 24.6% [3] - Veeva Systems currently has a market capitalization of $46.2 billion and anticipates a 14.6% growth in earnings for fiscal 2026 [5][6] Product Features - The Veeva China Campaign Manager integrates with the Veeva CRM suite, enhancing campaign execution through personalization, analytics, and coordination between sales and marketing [6][8] - Key features include advanced tagging and segmentation for precision targeting, customizable surveys for feedback, and a goal-oriented tracking system for campaign effectiveness [8][9] - The platform supports synchronized planning and execution across various engagement channels, allowing field representatives to dynamically adjust their strategies [8][9][10] Market Position - The launch positions Veeva Systems for long-term growth in one of the largest pharmaceutical markets globally, enhancing its competitive edge in Asia-Pacific [4][10] - Veeva's continued investment in region-specific tools like the Campaign Manager strengthens its role as a key technology enabler for pharmaceutical commercialization in the region [10]